ADIPOQ and hyperlipidemia: In addition to increased fat mass, hscEMC10 over-expressors exhibited hyperinsulinemia, hyperleptinemia, hyperlipidemia, and showed significantly lower circulating adiponectin (Supplementary Fig. 6G).